Anthropic’s IPO is now nearly 7 times oversubscribed, with 825 million shares priced in a range of $70 to $78. Underwriters are already considering whether to price it directly above $78. At the top of the range, the public offering could raise about $64.3 billion; add another $26 billion in private funding, and the total deal size approaches $90 billion, at a valuation of $1.4 trillion.

The action off-market is interesting too: ANT perpetual futures on Hyperliquid briefly hit $99, 27% above the top of the range—so it’s already been through a round of speculation before even listing. Retail investors have been allocated 20% of the offering, and Schwab, Fidelity, and Robinhood are all on the list of brokerages.

On one hand, the IPO is 7 times oversubscribed and annualized revenue has reached $81 billion; on the other, some are warning that orders aren’t commitments, and how much investors will actually get allocated remains to be seen. There’s plenty of excitement, but will the stock really hold at that $99 price on its first day of trading?